California's Bubble Baby Saga: CIRM Touts its Role in Maintaining the Once Abandoned Clinical Trial
UCLA updates status of the research, 28 children on the waiting list
California’s $12 billion stem cell agency played a key role in financing the research that has developed a successful treatment for the life-threatening “bubble baby” disease. And yesterday the agency celebrated that fact and the national recognition it received last month.
The “celebration” came on the blog of the Calif…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.